Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aspen Pharmacare Holdings | Johannesburg | Healthcare | Pharmaceuticals | ZAR 75.14B | 17x | -1.08 | ZAC 16,894 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.8% Upside | Upgrade to Pro+ | |
Life Healthcare | Johannesburg | Healthcare | Healthcare Providers & Services | ZAR 21.52B | 5.6x | 0.01 | ZAC 1,492 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.7% Upside | Upgrade to Pro+ | |
Netcare | Johannesburg | Healthcare | Healthcare Providers & Services | ZAR 17.14B | 12.5x | ZAC 8,563 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Netcare | Johannesburg | Healthcare | Healthcare Providers & Services | ZAR 17.14B | 12.5x | 0.74 | ZAC 1,373 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.2% Upside | Upgrade to Pro+ | |
Adcock Ingram Holdings | Johannesburg | Healthcare | Pharmaceuticals | ZAR 9.68B | 12x | -2.9 | ZAC 6,599 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3% Upside | Upgrade to Pro+ | |
Ascendis Health Ltd | Johannesburg | Healthcare | Pharmaceuticals | ZAR 488.09M | 8.5x | -0.45 | ZAC 78 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cilo Cybin Holdings | Johannesburg | Healthcare | Pharmaceuticals | ZAR 355.09M | 253.5x | ZAC 500 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |